Yu Waye Chu

Hoofd Techniek/Wetenschap/O&O bij CYTOMX THERAPEUTICS, INC.

Vermogen: 586 416 $ op 30-04-2024

56 jaar

Health Technology

Consumer Services

Actieve functies van Yu Waye Chu

Bedrijven	Functie	Begin	Einde
CYTOMX THERAPEUTICS, INC.	Hoofd Techniek/Wetenschap/O&O	17-07-2023	-

Bedrijven	Functie	Begin	Einde
FATE THERAPEUTICS, INC.	Hoofd Techniek/Wetenschap/O&O	18-04-2019	14-07-2023
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01-01-2009	01-04-2019

Princeton University	Undergraduate Degree
University of Rochester School of Medicine & Dentistry	Doctorate Degree

Internationaal

Verenigde Staten

Operationeel

Sectoraal

Health Technology	4
Consumer Services	3

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
FATE THERAPEUTICS, INC.	Health Technology
CYTOMX THERAPEUTICS, INC.	Health Technology

Bedrijven in privébezit	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology

Bedrijven in privébezit

Health Technology